With this in mind, GLP-1 medications can support more than just weight loss
A 2023 study published in the Journal of Clinical Endocrinology and Metabolism found that GLP-1 receptor agonist therapy in women with obesity and insulin resistance produced significant improvements in androgen levels, menstrual regularity, and metabolic markers, with effects most pronounced in women with baseline hyperinsulinemia, underscoring how tightly GLP-1 mechanisms are connected to broader hormonal function in women
Summary and future direction The inability of a medication to cross the BBB to achieve an effective therapeutic concentration in the brain has been the major cause of treatment failure for many brain diseases
The current study has its own limitations, no comparisons were made with patients on traditional AEDs or placebo and the short follow up duration are among these limitations
In adults, GH supports muscle protein synthesis, fat metabolism, bone density, immune function, sleep quality, energy levels, and tissue repair